Diabetic nephropathy: Renoprotective effects of GLP1R agonists and SGLT2 inhibitors.

Nat Rev Nephrol · 2017

Last updated 2026-05-28

Journal	Nat Rev Nephrol, 2017
Citations	29
Relative citation ratio	1.06
NIH percentile	52
Molecules	—
Conditions studied	Type 2 Diabetes, Chronic Kidney Disease

Full record and abstract on PubMed 28989173 ↗